tm logo
ZYUS
REGISTERED

on 06 Dec 2023

Last Applicant/ Owned by

ZYUS LIFE SCIENCES INC.

204-407 Downey RoadSaskatoon

SASKATCHEWAN

CA

S7N4L8

Serial Number

1930692 filed on 15th Nov 2018

Registration Number

TMA1212712 registered on 06th Dec 2023

Registration expiry Date

06th Dec 2033

Correspondent Address

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

ZYUS

Trademark usage description

pharmaceutical phytochemicals, namely, chemical additives and preparations for use in the manufacture of pharmaceuticals; cannabinoid and protein-base Read More

Classification Information


Class [001]
Pharmaceutical phytochemicals, namely, chemical additives and preparations for use in the manufacture of pharmaceuticals; cannabinoid and protein-based additives for use in the manufacture of pharmaceutical preparations


Classification kind code

11

Class [005]
Pharmaceutical preparations for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation, namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis; pharmaceutical preparations, namely, phytotherapeuticals containing cannabinoids and proteins for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation, namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis; natural health products for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation, namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis; cannabis substances for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis


Classification kind code

11

Class [041]
Educational and instruction services in the field of healthcare, namely, pharmaceuticals, cannabinoids and proteins for treatment of disease


Classification kind code

11

Class [042]
Research and development services in the fields of developing pharmaceuticals, cannabinoid and proteinbased pharmaceuticals, and plant genetics; software as a service in the fields of developing pharmaceuticals, cannabinoid and protein-based pharmaceuticals


Classification kind code

11

Class [044]
Healthcare services in the field of treating disease pain, nausea, epilepsy, multiple sclerosis, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis using cannabinoids and proteins; agricultural services in the field of cannabis cultivation and production; providing information in the field of healthcare, namely, and pharmaceuticals, cannabinoids and proteins for the treatment of disease


Classification kind code

11

Class [045]
Advocacy services in the field of healthcare and pharmaceuticals


Classification kind code

11

Mark Details


Serial Number

1930692

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 42
on 14th Jun 2023
Advertised
Submitted for opposition 27
on 19th May 2023
Approval Notice Sent
Submitted for opposition 26
on 19th May 2023
Approved
Submitted for opposition 15
on 13th Apr 2022
Correspondence Created
Submitted for opposition 22
on 14th Jun 2021
Search Recorded
Submitted for opposition 20
on 14th Jun 2021
Examiner's First Report
Submitted for opposition 135
on 27th Feb 2019
Amendment to Application
Submitted for opposition 31
on 20th Nov 2018
Formalized
Submitted for opposition 1
on 16th Nov 2018
Created
Submitted for opposition 30
on 15th Nov 2018
Filed